5/16
06:21 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
5/15
08:20 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at Stifel Nicolaus from $82.00 to $83.00. They now have a "buy" rating on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at Stifel Nicolaus from $82.00 to $83.00. They now have a "buy" rating on the stock.
5/14
10:18 am
aclx
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy [Yahoo! Finance]
Low
Report
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy [Yahoo! Finance]
5/14
08:07 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $85.00 price target on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $85.00 price target on the stock.
5/13
02:05 pm
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its price target lowered by analysts at HC Wainwright from $82.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its price target lowered by analysts at HC Wainwright from $82.00 to $80.00. They now have a "buy" rating on the stock.
5/10
04:32 am
aclx
Kite and Arcellx prepare to launch Phase III multiple myeloma trial [Yahoo! Finance]
Medium
Report
Kite and Arcellx prepare to launch Phase III multiple myeloma trial [Yahoo! Finance]
5/9
06:44 pm
aclx
Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/9
04:44 pm
aclx
Arcellx Provides First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Arcellx Provides First Quarter 2024 Financial Results [Yahoo! Finance]
5/9
04:12 pm
aclx
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program [Yahoo! Finance]
Medium
Report
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program [Yahoo! Finance]
5/9
04:05 pm
aclx
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Medium
Report
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
5/9
04:00 pm
aclx
Arcellx Provides First Quarter 2024 Financial Results
Medium
Report
Arcellx Provides First Quarter 2024 Financial Results
5/7
04:00 pm
aclx
Arcellx to Participate in Two Upcoming Investor Conferences
Low
Report
Arcellx to Participate in Two Upcoming Investor Conferences
5/7
08:02 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $81.00 price target on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $81.00 price target on the stock.
4/23
11:43 am
aclx
Should You Be Bullish on Arcellx (ACLX)? [Yahoo! Finance]
Low
Report
Should You Be Bullish on Arcellx (ACLX)? [Yahoo! Finance]
4/11
08:06 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $81.00 price target on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $81.00 price target on the stock.
4/4
04:00 pm
aclx
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
4/4
09:25 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its "outperform" rating re-affirmed by analysts at Scotiabank. They now have a $82.00 price target on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its "outperform" rating re-affirmed by analysts at Scotiabank. They now have a $82.00 price target on the stock.
3/20
04:00 pm
aclx
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Low
Report
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
3/18
03:05 pm
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $82.00 price target on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $82.00 price target on the stock.
3/18
02:52 pm
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at Needham & Company LLC from $72.00 to $81.00. They now have a "buy" rating on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at Needham & Company LLC from $72.00 to $81.00. They now have a "buy" rating on the stock.
3/7
07:30 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $81.00 price target on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $81.00 price target on the stock.
3/5
10:34 am
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at Truist Financial Co. from $57.00 to $87.00. They now have a "buy" rating on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at Truist Financial Co. from $57.00 to $87.00. They now have a "buy" rating on the stock.
3/2
07:54 am
aclx
Earnings Update: Arcellx, Inc. (NASDAQ:ACLX) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
Low
Report
Earnings Update: Arcellx, Inc. (NASDAQ:ACLX) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
2/29
04:00 pm
aclx
Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference
Low
Report
Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference
2/29
03:42 pm
aclx
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at HC Wainwright from $60.00 to $82.00. They now have a "buy" rating on the stock.
Low
Report
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at HC Wainwright from $60.00 to $82.00. They now have a "buy" rating on the stock.